<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11862455</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.659</article-id><article-id pub-id-type="other">EPP0536</article-id><article-id pub-id-type="pii">S092493382400659X</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Presentation</subject></subj-group></article-categories><title-group><article-title>I smell something weird - Ictal olfactory hallucinations in patients with primary brain tumors</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Mousinho</surname><given-names>M.</given-names></name><xref rid="aff1544" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor0520" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ant&#x000e3;o</surname><given-names>D.</given-names></name><xref rid="aff1545" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Soares</surname><given-names>A.</given-names></name><xref rid="aff1546" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Pimentel</surname><given-names>T.</given-names></name><xref rid="aff1545" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff1546" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Salgado</surname><given-names>D.</given-names></name><xref rid="aff1545" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Fernandes</surname><given-names>M.</given-names></name><xref rid="aff1545" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff1546" ref-type="aff">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="aff1544"><sup>1</sup>Mental Health Department, <institution>Local Health Unit of Baixo Alentejo</institution>, <city>Beja</city></aff><aff id="aff1545"><sup>2</sup>Neurology Department</aff><aff id="aff1546"><sup>3</sup>Neurophysiology Laboratory, <institution>Portuguese Institute of Oncology</institution>, <city>Lisboa</city>, <country>Portugal</country></aff><author-notes><corresp id="cor0520"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="634">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S317</fpage><lpage>S317</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S092493382400659Xa.pdf"/><abstract><sec id="sec3126"><title>Introduction</title><p>Ictal olfactory hallucinations (the experience of a smell due to a focal seizure in the absence of an environmental stimulus for the sensation) are rare. They often appear in a context of a brain tumor located in the orbitofrontal or mesotemporal region. However, their accurate prevalence, etiology and anatomical origin remains unclear, as few studies focused on this type of seizures specifically.</p></sec><sec id="sec3127"><title>Objectives</title><p>To evaluate the clinical, neurophysiological and imaging characteristics of patients with brain tumors and olfactory seizures.</p></sec><sec id="sec3128"><title>Methods</title><p>We present a 3-year retrospective patient record study carried out at the Portuguese Institute of Oncology in Lisbon. Clinical records of 572 patients admitted due to a primary Central Nervous System (CNS) tumor, for their first neuro-oncology appointment, between July 2020 and July 2023, were reviewed.</p></sec><sec id="sec3129"><title>Results</title><p>8 patients with olfactory seizures were identified. Five were men. The mean age was 57.75 (ages&#x000a0;between 15 and 70 years old). In seven patients, olfactory seizures constituted the initial clinical presentation of the tumor. In two patients, focal olfactory seizures had progression to bilateral tonic clonic. Most seizures were perceived as unpleasant (smells of metal, ammonia, &#x0201c;hot blood&#x0201d;, &#x0201c;dead bodies&#x0201d; were described). Tumors involved the temporal lobe in all patients, the insula in two of them and, for the majority, the lesion was right-sided. Six&#x000a0;patients were diagnosed with Glioblastoma IDH wildtype (Grade 4, WHO), one patient with Oligodendroglioma, IDH-mutated and 1p/19q-codeleted (Grade 2, WHO) and the pediatric patient with a diffuse pediatric type high-grade glioma, H3 and IDH wildtype. The average follow-up time was 6.8 months, two patients died.</p></sec><sec id="sec3130"><title>Conclusions</title><p>This is the first retrospective study carried out in Portugal that documents the prevalence of olfactory seizures in patients with primary CNS tumors. Given the scarce literary evidence, we consider that olfactory seizures may be more frequent than documented, particularly in the presentation of brain tumors. As so, active semiological investigation may contribute to an earlier diagnosis.</p></sec><sec id="sec3131"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>